Rapid Micro Biosystems, Inc.
RPID
$3.65
-$0.02-0.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.33% | 8.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.33% | 8.07% | |||
| Cost of Revenue | -6.02% | 3.65% | |||
| Gross Profit | -58.82% | 57.72% | |||
| SG&A Expenses | 8.11% | -13.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.27% | -6.09% | |||
| Operating Income | -14.00% | 15.03% | |||
| Income Before Tax | -16.34% | 14.46% | |||
| Income Tax Expenses | 177.78% | -169.23% | |||
| Earnings from Continuing Operations | -16.52% | 14.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.52% | 14.63% | |||
| EBIT | -14.00% | 15.03% | |||
| EBITDA | -15.37% | 16.87% | |||
| EPS Basic | -15.94% | 14.85% | |||
| Normalized Basic EPS | -15.70% | 14.64% | |||
| EPS Diluted | -15.94% | 14.85% | |||
| Normalized Diluted EPS | -15.70% | 14.64% | |||
| Average Basic Shares Outstanding | 0.51% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||